Strategic Investment Solutions’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Strategic Investment Solutions’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-35	Closed	-$3.83K	–	722
2024 Q2	$3.83K	Buy	+35	New	+$3.83K	﹤0.01%	448
2023 Q4	–	Sell	-2,205	Closed	-$237K	–	1205
2023 Q3	$237K	Buy	2,205 +2,170	+6,200%	+$233K	﹤0.01%	484
2023 Q2	$3.51K	Hold	35	–	–	﹤0.01%	701
2023 Q1	$3.82K	Buy	+35	New	+$3.87K	﹤0.01%	796

Other funds holding HZNP

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Strategic Investment Solutions's HZNP Position: Q3 2024 in Review

Strategic Investment Solutions sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2024, closing a stake of 35 shares — an estimated $3.83K sold.

Strategic Investment Solutions first reported a position in HZNP in Q1 2023 and held it in 4 quarters. The position peaked at $237K in Q3 2023. 1 fund tracked by Wall St. Rank holds HZNP as of Q3 2024.

Strategic Investment Solutions reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2024 after selling out during the quarter.
Strategic Investment Solutions sold 35 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2024, an estimated $3.83K.
Strategic Investment Solutions first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023 and held it in 4 quarters.
Strategic Investment Solutions's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $237K in Q3 2023.
1 fund tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2024.

Based on Strategic Investment Solutions's 13F filing for Q3 2024, filed 23 Oct 2024.